Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, March 20, 2023
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
[ Mon, Mar 20th 2023
] - WOPRAI
Subash Chandra Upgraded (ASPN) to Strong Buy and Held Target at $14 on, Mar 20th, 2023
Subash Chandra of Benchmark, Upgraded "Aspen Aerogels, Inc." (ASPN) to Strong Buy and Held Target at $14 on, Mar 20th, 2023.
Subash has made no other calls on ASPN in the last 4 months.
There are 3 other peers that have a rating on ASPN. Out of the 3 peers that are also analyzing ASPN, 0 agree with Subash's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Subash
- Alexander Potter of "Piper Sandler" Maintained at Buy with Decreased Target to $24 on, Wednesday, February 22nd, 2023
- George Gianarikas of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $18 on, Friday, February 17th, 2023
- Christopher Souther of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $26 on, Tuesday, December 13th, 2022
